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ABSTRACT
Objectives This study aimed to achieve an expert 
consensus on how to define and group footwear 
interventions for children, with a further focus on the 
design characteristics and prescription of off- the- shelf 
stability footwear for children with mobility impairment.
Setting A group of multinational professionals, from 
clinicians to those involved in the footwear industry, were 
recruited to ensure a spectrum of opinions.
Participants Thirty panellists were contacted, of which 
24 consented to participate and six withdrew before round 
1, a further two withdrew after round 1. Sixteen panellists 
completed the consensus exercise.
Primary and secondary outcome measures A Delphi 
consensus method was employed with round 1 split into 
three sections: (1) terms and definitions, (2) specifics of off- 
the- shelf stability footwear design and (3) criteria for clinical 
prescription of off- the- shelf stability footwear. The panel was 
asked to rate their level of agreement with statements and to 
provide further insights through open- ended questions. The 
opinions of the experts were analysed to assess consensus 
set at 75% agreement or to modify or form new statements 
presented through the subsequent two rounds.
Results Therapeutic footwear was the agreed term to 
represent children’s footwear interventions, with grouping 
and subgrouping of therapeutic footwear being dependent 
on their intended clinical outcomes (accommodative, 
corrective or functional). Both the heel counter and topline 
as well as the stiffness and width of the sole were identified 
as potentially influencing mediolateral stability in children’s 
gait. A consensus was achieved in the prescription criteria 
and outcome measures for off- the- shelf stability therapeutic 
footwear for cerebral palsy, mobile symptomatic pes planus, 
Duchenne muscular dystrophy, spina bifida and Down’s 
syndrome.
Conclusions Through a structured synthesis of expert 
opinion, this study has established a standardisation of 
terminology and groupings along with prescription criteria 
for the first time. Reported findings have implications for 
communication between stakeholders, evidence- based 
clinical intervention and standardised outcome measures to 
assess effectiveness.
INTRODUCTION
Footwear is a fundamental common boundary 
between the ground and the foot in daily 
activities; it modifies forces and sensory stim-
ulus with demonstratable effects on children’s 
gait.1–3 Correspondingly footwear has been 
used both historically and in modern health-
care practice as an assistive aid for children 
with mobility impairment.4 5 However, a recent 
scoping review6 highlighted that footwear 
as a clinical intervention for children lacks a 
common understanding of terms and defini-
tion as to the specifics of its clinical role. The 
development of recognised terms, definitions 
and characteristics of a healthcare interven-
tion afford an understanding of how it should 
work, the value it should provide, who should 
benefit, how to measure its success, what risks 
are present and what is and is not included 
within the intervention.7 8 The scoping review6 
demonstrated that numerous terms have been 
used in the literature concerning clinical foot-
wear interventions, including orthopaedic 
shoes, rehabilitative boots, modified shoes, 
supportive shoes and special shoes. Addition-
ally, there was no clear definition of the clin-
ical role and outcome measures to classify 
and group the range of available children’s 
footwear interventions. The results of the 
Strengths and limitations of this study
 ► A multinational sample of professionals from cli-
nicians to those involved in the footwear industry 
was sought to ensure a spectrum of opinions were 
included.
 ► Analysis followed a standard mixed- method ap-
proach for Delphi consensus surveys and employed 
both qualitative and quantitative analysis.
 ► The study was limited to countries with English as 
their first language, and there may be differences in 
expert opinions outside the selected expert’s coun-
tries (Australia, UK and USA).
 ► This research paves the way for the development of 
appropriate mechanical testing methods for off- the- 
shelf therapeutic stability footwear.
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scoping review suggested therapeutic footwear as a poten-
tial overarching term to represent the myriad roles and 
designs of children’s clinical footwear interventions, with 
three primary groupings of therapeutic footwear catego-
rised according to common identified clinical roles. The 
groupings were: corrective (footwear designed to bring 
about the correction of congenital skeletal lower limb 
alignment), accommodative (footwear designed to reduce 
stresses on children’s foot deformity through the matching 
of footwear dimensions to the child’s foot) and functional 
(footwear designed to improve dynamic gait parameters of 
mobility- impaired children, reducing pathological move-
ments and facilitating typical walking patterns inclusive of 
stability).6
Among the therapeutic footwear groupings suggested 
in the scoping review,6 those that offered a stabilising role 
were the most studied. Research has demonstrated poten-
tially beneficial clinical outcomes to children with mobility 
impairment with increased velocity and lowered medi-
olateral excursions of the centre of mass in walking.9–11 
Children’s stability footwear may be bespoke or have 
uppers that come in a range of modular adaptions but 
are most commonly made to a manufacturer’s standard 
stock model, which are termed off the shelf.10 12 The body 
of research concerning off- the- shelf stability footwear has 
chiefly focused on its biomechanical effects. However, the 
specific standard design characteristics for this footwear 
that are requisite for stability were not clearly identified 
or consistently reported in the literature.6 9 The lack of 
recognised characteristics of an intervention prevents a 
common understanding of how it should work clinically7 8 
and preclude a meaningful comparison throughout any 
evidence- based research.9 Thus, it is important that 
a consensus understanding of design characteristics 
required to enhance stability during gait is obtained, 
from both a manufacturing and clinical perspective, for 
this footwear.
In respect to who may benefit from this intervention,7 8 
there were seven childhood mobility impairments consid-
ered for off- the- shelf stability footwear intervention among 
the research identified through the scoping review: cere-
bral palsy, pes planus, toe walking, Duchenne muscular 
dystrophy, spina bifida, Down’s syndrome and intoeing.6 
However, there appeared to be no clear prescription 
criteria for the use of off- the- shelf stability footwear in these 
conditions. Specific gaps in prescription criteria included 
the stated clinical role, the grade/severity of the condition 
when this footwear should be used as a sole assistive aid or 
an adjunct to other aids such as ankle foot orthoses (AFOs) 
and the suitable age range for intervention.6 9 In addition, 
there appears to be no standardised set of agreed outcome 
measures, both physical and psychosocial, to ascertain the 
effectiveness of this footwear.9 Identification and consensus 
agreement of outcome measures for both research and 
clinical practice allows for a unified measure of the effec-
tiveness of an intervention, informing on value- driven 
healthcare and the development of a consistent evidence 
base.13
Although terminology and means of grouping clinical 
footwear interventions as a whole have been suggested by 
a synthesis of the available research,6 9 a common under-
standing and usage of these terms would require an opinion 
on their practical application from experts who provide 
footwear to children with mobility impairment. Once the 
overall groupings and terminology of clinical footwear 
interventions have been established among experts in this 
area, it will be possible to identify and define individual 
intervention footwear categories for childhood mobility 
impairment, such as stability footwear. Off- the- shelf stability 
footwear appears to offer a beneficial effect on the broadest 
range of childhood mobility impairments.6 9 However, 
as stated, a common understanding of the specifics and 
purpose of their design and the proposed clinical outcomes 
of this treatment is not apparent in the research.6 9
Where there is contradictory or insufficient information, 
the ability to formulate effective clinical reasoning can be 
affected; here consensus surveys such as the Delphi offers 
a valid and reliable method of determining expert opinion 
to inform on these areas.14–16 Delphi surveys incorporate 
the collective opinion of a panel of experts fed back to the 
panel through a series of iterative rounds in an anonymised 
and controlled manner, with the underlying goal to achieve 
expert consensus on a certain issue where no agreement 
previously existed. This technique has been used success-
fully to achieve professional consensus on school footwear 
design17 and the use of orthoses for mobility impair-
ment.18 19 The only previous study relating to the synthesis 
of expert opinion on footwear interventions was performed 
by Staheli and Giffin in 1980.4 This was a single round 
cross- section survey of practice and opinion that lacked 
the staged systematic approach of a Delphi survey and was 
restricted to the correction of musculoskeletal alignments 
that are mainly found in typically developing children. The 
survey did not consider the footwear terminology used, the 
purpose of the specific designs of footwear or any effects 
on children’s gait.4 Establishing a common understanding 
of terms, definitions and groupings of clinical footwear as 
a whole, alongside design characteristics and prescription 
criteria for specific footwear groupings, may be achieved 
by conducting a Delphi consensus with experts in the field 
of clinical footwear provision and design. The consensus 
opinion may then be used to develop consistent terms and 
definitions for footwear interventions and prescription 
criteria and design characteristics for off- the- shelf stability 
footwear for children with mobility impairment.
Aims and objectives
The overall aim of this study was to achieve an expert 
consensus on how to define and group clinical foot-
wear interventions for children, with a further focus on 
the design characteristics and clinical prescription of 
off- the- shelf stability footwear for children with mobility 
impairment.
The objectives were:
 ► To establish expert consensus on the terms, defini-
tions and groupings of children’s clinical footwear 
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interventions, providing a consistent and common 
clinical understanding to identify and categorise the 
purpose of these footwear types as an assistive aid for 
children.
 ► To establish a consensus of expert opinion of the ideal 
design characteristics of off- the- shelf stability footwear 
and the purpose of these characteristics.
 ► To develop expert consensus recommendations for 
the prescription criteria and outcome measures for 
off- the- shelf stability therapeutic footwear.
METHOD
This Delphi consensus study followed the methodological 
and reporting recommendations suggested by Keeney, 
Hasson and Mckenna.20 21 The development and purpose 
of this survey were informed by scoping and systematic 
reviews performed by the authors.6 9
All panellists provided written informed consent to 
participate in this study.
Patient and public involvement
Due to the nature of this study, no patients or public were 
involved in the design, implementation or analysis of 
results.
Identifying panellists
Experts were recruited by the purposeful sampling of 
individuals meeting specific criteria:
 ► Registered practitioner in healthcare or clinical foot-
wear manufacture.
 ► ≥10 years of practice in clinical footwear provision/
manufacture.
 ► ≥25% clinical caseload involving the provision of foot-
wear interventions to children with mobility impair-
ment or ≥25% of their workload involved with the 
design or manufacture of footwear intended for ther-
apeutic use in children with mobility impairment.
Recruitment was initially through professional networks 
of the research team and subsequently recruited experts 
were asked to identify additional experts who they felt 
met the criteria for this study. A multinational sample 
of professionals from clinicians, researchers and those 
involved in the footwear industry was sought to ensure 
a spectrum of opinions were included. Although there 
are no agreed definitions for an effective size convention 
ranging from 10 to 100 panellists within the literature,22 
researchers have suggested a sample size of 10 will provide 
a diversity of expert opinion.23
Contacting experts
Experts were contacted with the information sheet by 
email, with consent and a participant professional charac-
teristic survey captured by Microsoft Forms.
Questionnaire design
The study took the form of a modified Delphi15; the first 
round was informed by scoping and systematic reviews of 
research in relation to children’s clinical footwear inter-
ventions6 9 and benchtop analysis of design characteristics 
Figure 1 An example of a question from section 1 exploring consistent terms and definition of clinical footwear interventions (* 
indicates required answer).
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of a range of off- the- shelf footwear proposed to offer a 
stabilising effect on mobility impaired children. This 
approach allowed the development of informed ques-
tions from the available evidence. The survey consisted of 
closed- ended ranked and option questions, with ranked 
questions using a 7- point Likert scale. Open- ended ques-
tions were also provided to explore the panellists’ opin-
ions on the statements and questions posed and to allow 
them to offer alternatives or raise further salient items 
in relation to children’s clinical footwear interventions. 
The first round of the survey, therefore, captured quali-
tative and quantitative data. This generated a combined 
synthesis of the current literature evidence base in rela-
tion to children’s clinical footwear interventions along-
side that of the experts’ opinions from working in the 
area of clinical footwear provision.
The survey was designed by the first author with cali-
bration and modification of questions among all authors. 
The survey was also piloted on an expert in clinical foot-
wear provision to ensure the questions were appropri-
ately framed and phrased to avoid ambiguity or multiple 
events within any question.24 The first round consisted of 
three sections:
Section 1 asked the panellists for their opinion on 
consistent terms, definitions and groupings of clin-
ical footwear interventions for children with mobility 
impairment. An example of the type and structure of the 
questions is provided in figure 1, with the full section 1 
survey available in online supplemental appendix S1.
Section 2 asked the panellists for their opinion on the 
ideal design characteristics of off- the- shelf stability foot-
wear and the purpose of these characteristics. An example 
of the type and structure of the questions is provided in 
figure 2, with the full section 2 survey available in online 
supplemental appendix S2.
Section 3 asked the panellists for their opinion on the 
prescription criteria of issuing commercially available off- 
the- shelf stability footwear in a range of mobility impair-
ments and the outcome measures to be used to assess the 
effectiveness of this footwear. An example of the type and 
structure of the questions is provided in figure 3, with 
the full section 3 survey available in online supplemental 
appendix S3.
The panellists were given instructions on how to 
complete the survey in the introduction of each section.
Distribution
The survey was distributed among panellists electroni-
cally via Microsoft Forms. Panellists were reminded to 
complete the survey 1 week before the deadline. Late 
responders were followed up and offered an appropriate 
extension if required.
Figure 2 An example of a question from section 2 exploring recognised design characteristics of children’s off- the- shelf 
stability footwear (* indicates required answer).
 on A









pen: first published as 10.1136/bm





5Hill M, et al. BMJ Open 2021;11:e051381. doi:10.1136/bmjopen-2021-051381
Open access
Analysis of results
Analysis followed a standard mixed- method approach for 
Delphi consensus surveys and employed both qualitative 
and quantitative analysis. The combined findings were 
used to inform the development of subsequent rounds 
of Delphi (two and three) in addition to the final results.
Analysis of open- ended questions involved an inductive 
themed content analysis framework performed by the 
first author.25 The process involved the identification of 
statements that were the same or could be constructed 
to mean the same thing. These statements were grouped 
together, and themes were developed around similar 
statements. Once statements were grouped under a 
common theme, a decision was made among the research 
team as to whether these themes should be collapsed into 
one statement to be presented to the Delphi panel in the 
subsequent round. Unique statements that did not fall 
into any common theme were kept as the original state-
ments. The wording of all statements was assessed by the 
research team for potential multiclauses and ambiguity.
The grouped themed and unique statements were 
presented to the panellists alongside a summary of the 
collective panellists’ reasoning in rounds 2 and 3. These 
were in a series of ranked Likert scale questions or options 
alongside the original statements from round 1 or 2. 
Rounds 2 and 3 followed the same format of round 1 with 
three sections (online supplemental appendices S1–3).
Descriptive statistics: central tendency and dispersion 
of the responses (median analysis, IQR) and % frequency 
to the ranked questions were fed back to the panellists in 
rounds 2 and 3 for an estimation of the general response 
of the other expert panellists (online supplemental 
appendices S1–3). The quantitative values were also 
recorded for consistency analysis across the rounds.
Consensus
There is no agreed guidance on consensus but is often 
achieved through generating a predetermined percentage 
level of consensus of ranked questions or panellists 
preferred option (frequency).14 15 The range of preset 
agreement is variable among Delphi studies; however, a 
value of 75% is a commonly reported value26 and the one 
chosen to define consensus among the recruited panel 
in the present study. Statements would reach consensus 
when there was 75% or greater frequency of response 
for a preferred option or ranked questions of ‘agree’ to 
‘strongly agree’.
Cut-off
The Delphi was set a priori to run over three rounds or if 
there was a greater than 30% drop off of panellists.
RESULTS
Thirty panellists were contacted in January 2020, of which 
24 consented to participate; six participants withdrew 
from the study prior to commencement of the first round. 
Eighteen panellists participated in round 1; the panel 
consisted of orthotists, podiatrists and a physiotherapist 
with a range of experience and roles in clinical footwear 
provision for children, including direct patient contact, 
education, research and commercial sales and manufac-
ture. The international panel was composed of panellists 
from the UK, Australia and the USA; a full breakdown 
of the panellists' characteristics are provided in (table 1).
Of the 18 panellists, 16 completed all rounds of the 
Delphi survey resulting in an 11% drop off from the 
initial round (figure 4). From the initial 45 statements 
(11 in section 1, 27 in section 2 and 7 in section 3), a 
Figure 3 An example of a question from section 3 exploring prescription criteria for the provision of children’s off- the- shelf 
stability footwear.
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further 238 statements were developed or modified from 
panellist feedback (figure 4) for a total of 283 statements. 
Consensus agreement among the panel was reached on a 
total of 150 statements (figure 4). The statements for each 
section inclusive of the original, modified and those that 
reached consensus are found in supporting information 
files (online supplemental appendix S4–6). The results 
for each section are presented and discussed separately.
Section 1
The 11 consensus statements from section 1 were taken 
forward to establish consistent terms and definitions to 
broadly group and categorise children’s clinical foot-
wear interventions. There was a considerable majority 
consensus of the panel (81% agreement) who favoured 
therapeutic footwear as the overarching term for chil-
dren clinical footwear interventions (figure 5). This term 
was felt by the majority of the panel to reflect the holistic 
aspect of footwear interventions on childhood mobility 
rather than be limited to aspects of aligning body struc-
ture that would be suggested by ‘orthopaedic’ and 
‘orthotic’. A broad overarching definition was established 
by panellists (82% agreement) for these interventions as:
Footwear that is designed or adapted specifically to 
protect, support, align, prevent, or correct foot de-
formity, or to assist mobility and standing in children.
This definition comprised the scope of the potential 
role of footwear as a clinical intervention while also recog-
nising that designs may incorporate specific therapeutic 
footwear or standard shoes that are adapted to meet a clin-
ical purpose. Groupings of footwear fell under the overar-
ching term therapeutic footwear (100% agreement), and 
panellists felt they should be grouped and categorised 
according to intended clinical outcomes of the compo-
nents of the footwear (100% agreement). This was modi-
fied from the suggested method of groupings from the 
scoping review6 in which the groupings assigned footwear 
as an individual design. The current grouping recognised 
that footwear might have more than one clinical role, that 
is, footwear may have both a direct functional component 
on gait and an accommodative component of the child’s 
foot deformity. The main groupings of therapeutic foot-
wear were those offered in round 1, which were taken 
from the scoping review6: accommodative, corrective and 
functional (figure 5). However, the definitions were modi-
fied by panellist’s feedback with all achieving consensus 
in the second round:
Accommodative footwear is children’s therapeutic 
footwear that is designed to prevent deterioration of 
children’s foot deformities through the dimensional 
matching of the footwear to the child’s foot. (76% 
agreement)
Corrective footwear is footwear that is designed or 
adapted to support correction of congenital or ac-
quired foot and ankle deformity in children. This 
may be secondary to a primary corrective measure 
such as serial casting or surgery. (82% agreement)
Functional footwear is children’s therapeutic foot-
wear that is designed or adapted to directly assist mo-
bility and standing in children. (76% agreement)
Panellists felt that functional footwear could be 
placed into subgroupings dependent on the design and 
intended clinical outcomes of the footwear similarly to 
that suggested for the main groupings of therapeutic 
footwear (76% agreement). The panellists favoured the 
subgrouping of stability footwear suggested from the 
scoping review provided in round 1 (94% agreement) 
(figure 5). However, the definition was modified by panel-
lists’ feedback and did not achieve consensus until the 
third round:
Stability Footwear is footwear that is designed to as-
sist mobility and standing in children by influencing 




Experience with clinical 
footwear provision for 
children
Median 18 years IQR 11.75
% workload dedicated 
to either: assessment, 
manufacture or commercial 
distribution of footwear 
interventions for children 
with mobility impairment
Median 36.5% IQR 25%
Profession:
  Orthotist 10 55.60%
  Physiotherapist 1 5.60%
  Podiatrist 7 38.80%
Professional role
  Clinician 5 27.80%
  Clinician; researcher 3 16.70%
  Clinician; education 3 16.70%
  Clinician; education; 
researcher
3 16.70%
  Clinician; commercial 
(sales and manufacture)
2 11.10%
  Clinician; researcher; 
commercial (sales and 
manufacture)
1 5.60%
  Clinician; education; 




  PhD/professional 
doctorate
5 27.80%
  Master‘s degree 5 27.80%
  Bachelor‘s degree 6 33.30%
  Professional diploma 2 11.10%
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movements and potentially proprioception of the 
foot and ankle. (94% agreement)
Panellists felt that the separate subgroupings of lift 
(raise*), rounded bottom (rocker bottom*) suggested 
from the scoping review in round 1 should be considered 
to fall collectively under one subgrouping. Therefore, a 
new separate subgrouping of functional footwear adapted 
sole was suggested from panellist feedback; this reached 
consensus in round 2 (76% agreement) (*preferred alter-
native terminology suggested by the majority of panellists 
in round 1) (figure 5). This was defined as:
A range of customised sole or heel adaptions to any 
suitable children’s footwear, with the adaptions de-
signed to assist mobility or standing in children.
From panellist feedback, the subgrouping of adapted 
sole recognised that there is a range of sole adaptions 
offering varied functional roles broader than stability. 
However, it was beyond the scope of the current Delphi 
to fully categorise and define the many sole adaptions that 
could fall into this subgrouping. Further detail on panellist 
opinion in the development of the subgrouping adapted 
sole may be found in online supplemental appendix S4.
Figure 4 The Delphi survey three- round process and individual sections results.
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Section 2
The 52 consensus statements from section 2 concerning 
the specific ideal design characteristics and purpose of 
off- the- shelf stability therapeutic footwear were distrib-
uted in nine regions of the shoe: topline, upper, facings 
and fastenings, heel counter/stiffener, heel, inlay, sole 
unit, sole rocker, in addition to overall consideration of 
the footwear’s mass (table 2). Three key themes emerged 
from panellist feedback concerning the ideal design char-
acteristics and their purpose those of stability, ergonomics 
and aesthetics (table 2). Stability was felt to be achieved 
by material stiffens of the heel counter (81% agreement), 
which may be assisted by an increased topline height 
in offering mediolateral stability to the foot and ankle 
(81% agreement). Panellists also felt that the fitting of 
the shoe inlay/insole to the child’s heel should not be 
overlooked to increase vertical ground reaction forces in 
this area in addition to the firm anchorage of the counter 
to the welt and outer sole (88% agreement) (table 2). 
Although a proprioceptive effect of the heel counter and 
topline was suggested by some panellists, full consensus 
Figure 5 Terms and groupings of clinical footwear 
interventions for children derived from section 1.
Table 2 Themes of the ideal design specifics and purpose of off- the- shelf therapeutic stability footwear derived from section 
2
Theme Region Dimension/manufacture Material/properties
Stability Heel counter/stiffener Extended to midfoot and towards topline.
Robust anchorage to welt and outsole.
Stiffened material.
Topline Extended above ankle
To assist leverage of heel counter.
Leather.
Outer sole Wider than heel cup of upper
Range of tread depths.
Deepened tread for uneven terrain.
Shallower for indoor use to avoid catching on the 
walking surface.
Minimal heel forefoot differential to maximise stability.
Stiffer at the heel and midfoot.
Hard wearing sole material.
Upper   Leather with stiffened material 
properties.
Inlay/insole Contoured to cup the child’s heel to improve the 
rearfoot fit.
  
Fastenings/facings Facings extended to midfoot. Lace fastenings.
Forefoot rocker Should not be so large to affect ground clearance in 
swing.
  
Ergonomics Heel counter/stiffener Range of available extensions to accommodate ankle 
anatomy.
  
Topline Padded collar and contoured to ankle anatomy.   
Outer sole Flexibility focused at the toe flex line.   
Upper Range of available dimensional adaptions to 
accommodate foot anatomy.
Tongue adapted to avoid slippage under fastenings.
Tongue length to provide comfort from fastenings.
Range of materials to allow 
breathability in warm climates.
Wipeable material dependent on 
user’s continence.
Fastening/facings Facings extended to toe box to allow greater access 
to footwear for limited foot and ankle mobility.
Velcro or lace dependent on the 
patient’s dexterity.
Inlay/insole Contoured to cup the child’s heel to improve rearfoot 
fitting.
Deep enough to simulate potential prescriptive 
orthoses.
  
Footwear kept to the lowest reasonable mass to reduce the physiological cost to a child in mobility.
Aesthetics Upper Range of colours. Range of material.
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(69% agreement) could not be achieved as a number of 
panellists were not convinced that the current evidence 
base supported the design components influence on 
proprioception. Other design features that were thought 
to impart stability and reached consensus were the: width 
of the heel in relation to the upper (87% agreement), 
stiffness of the outsole at the midfoot and rearfoot (88% 
agreement), tread depth of the outsole (87% agreement), 
lace fastenings (81% agreement) and leather upper of 
high tensile strength properties (93% agreement). The 
overall mass of the shoe was not thought to improve the 
stability properties of the shoe; it was, however, proposed 
and achieved consensus as a potential cause of instability 
in the swing phase of gait if too heavy.
The second key theme concerning the ideal design 
characteristics of off- the- shelf stability therapeutic foot-
wear was in relation to ergonomics. Ergonomic aspects 
considered the fit and comfort of the shoe during wear 
and the ease in which the shoe could be donned and 
doffed on a child’s foot with limited mobility. Origi-
nally in round 1, specific statements were presented to 
the panellists in relation to the design of this footwear, 
for example, ‘Extended topline height above the ankle’ and 
‘The fastening should have the following characteristics: Lace’. 
However, panellist opinion and feedback established a 
consensus preference to a pragmatic range of ergonomic 
options based on the child’s ability, age and clinical need 
over the course of rounds 2 and 3, for example:
The topline extension should come in an optional 
range both above and below the ankle dependent 
on the patient’s ability and needs. (93% agreement), 
and The Fastenings should be Optional dependent 
on patient’s ability and desired goal (eg, Velcro for 
limited hand dexterity, lace for greater stability). 
(93% agreement)
Panellists felt that the upper (93% agreement) and heel 
counter (80% agreement) should be available in a range 
of dimensions for any given size of off- the- shelf stability 
therapeutic footwear to accommodate a child’s foot and 
ankle anatomy. The material of the upper should come 
in a range of materials to include breathable and wipe-
able fabrics for warm climates and issues with continence 
(100% agreement). The topline should be padded at 
the collar (88% agreement) and contoured to the ankle 
anatomy (80% agreement) to minimise mechanical stress 
to this region. Facings should be offered extended to the 
toe box to allow easy access (donning and doffing of the 
footwear) for children with limited movement of the foot 
and ankle (93% agreement).
Fastening should be in both lace and Velcro fastening 
to accommodate children’s manual dexterity and allow 
a degree of independence (93% agreement). The mass 
of the footwear should be the lowest reasonable to 
reduce the physiological cost of walking (100% agree-
ment). However, it was recognised that older children 
might require heavier footwear to account for increased 
mobility or enhanced stability requirements such as a 
stiffened outsole or extended heel counter that may addi-
tionally increase the footwear’s mass (93% agreement). 
A consensus of the panellist was reached concerning 
the inlay/insole of off- the- shelf stability footwear, in that 
contouring at the heel improves rearfoot fit (81% agree-
ment), and the inlay should be removable and thick 
enough to represent replacement by a possible adjunct 
orthosis (100% agreement). However, the specifics of 
the design in relation to contouring to the arch and heel 
failed to reach a consensus (63% agreement). Similarly, 
the purpose of a forefoot rocker to facilitate forward 
progression in gait and not affect the swing phase of 
gait reached a consensus (93% agreement). However, 
the standard design requirements of the rocker did not 
reach a consensus (56% agreement). Aesthetics of the 
footwear was proposed by the panellists in recognition 
of the psychosocial needs of children and felt that the 
visual appeal of the shoe was important to facilitate social 
interaction with peers with this statement receiving 100% 
agreement among the panel on initial consideration in 
round 2.
Section 3
The 87 consensus statements concerning children’s 
mobility impairments suitable for off- the- shelf stability 
therapeutic footwear intervention resulted in consensus 
recommendations for the prescription criteria and 
outcome measures for five of the initial seven conditions: 
cerebral palsy (92% agreement), mobile symptomatic pes 
planus (86% agreement), Duchenne muscular dystrophy 
(92% agreement), spina bifida (80% agreement) and 
Down’s syndrome (85% agreement) (tables 3–4). 
Five further conditions were suggested and reached a 
consensus among the panel: Charcot- Marie- Tooth (92% 
agreement), hypermobility (Ehlers- Danlos type) (92% 
agreement), developmental coordination disorder (100% 
agreement), Rett’s syndrome (80% agreement) and 
chronic lateral ankle instability (77% agreement) (online 
supplemental appendix S6). However, the prescription 
criteria and outcome measures for the treatment of these 
further conditions were unable to be explored without 
further extending the Delphi survey and risking panellist 
fatigue.14
In relation to the prescription criteria for off- the- shelf 
stability therapeutic footwear, there were three areas that 
reached a general consensus for the five conditions:
1. The footwear provides mediolateral stability at the foot 
and ankle in walking and standing. Meaning it could 
act as both a walking aid and transfer aid (range 79%–
88% agreement) (table 3).
2. The provision of off- the- shelf stability therapeutic foot-
wear should only be issued to children with mobility 
impairment after a critical assessment of the child’s 
mobility needs in respect to other assistive aids or foot-
wear modifications and with clear clinical outcomes 
(range 86%–92% agreement). Panellists voiced their 
concern that this footwear had been historically uncrit-
ically prescribed in the conditions exampled. Panellists 
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felt foot orthoses serving similar function are less ob-
trusive and potentially cheaper. Consequently, a con-
sensus (86% agreement) was reached that off- the- shelf 
stability therapeutic footwear should only be used as 
a secondary line of intervention for symptomatic pes 
planus where foot orthoses had failed to resolve symp-
toms.
3. In relation to the suitable age range for off- the- shelf 
stability therapeutic footwear intervention, a prag-
matic approach to initiation and endpoints reached 
consensus in that it should be based on the functional 
ability and the mobility needs of the child rather than 
a specified age (range 77%–94% agreement).
Other areas suggested by panellists were concerning 
the use of this footwear as a sole aid or adjunct to other 
assistive devices. Most indications for the use of off- the- 
shelf stability therapeutic footwear was as an adjunct to 
other assistive devices (range 77%–92% agreement) to aid 
mediolateral stability in walking and standing (table 3). 
These other assistive devices included foot orthoses, 
AFOs, knee ankle foot orthoses (KAFOs), hip knee ankle 
foot orthoses and walking and standing frames. Indica-
tions for off- the- shelf stability therapeutic footwear as a 
sole aid were limited to low- grade cerebral palsy with no 
tonal issues (81% agreement) and the early walking stage 
of individuals with Down’s syndrome (94% agreement). 
Table 3 Prescription criteria for off- the- shelf stability therapeutic footwear
Condition Indications for treatment Sole or adjunct treatment
Cerebral palsy Where mediolateral stability 
is required for standing and 
walking.
Sole aid
May be used to assist both foot and ankle walking stability in children with 
GMFCS 1 and no significant tonal issues.
Adjunct
Used simultaneously with other assistive aids* to assist walking and 
standing in ambulant children GMFCS 1–3 with tonal issues.
Used simultaneously with other assistive aids* to assist standing in non- 
ambulant children GMFCS 4.
Down’s syndrome Sole aid




1. Foot orthoses to assist walking in individuals with ankle instability.





1. Foot orthoses to assist foot and ankle stability in early ambulatory 
stages.
2. AFOs and walking frames to assist walking in late ambulatory stages.




1. Foot orthoses to assist foot and ankle stability in sacral level 1 
(meningocele).
2. AFOs and walking frames to assist walking and standing in lumbar level 
4–5 (meningocele and myelomeningocele).
3. HKAFO or KAFO and walking frames to assist walking and standing in 
lumbar level 1–3 (meningocele and myelomeningocele).
Symptomatic 
mobile pes planus
Secondary line intervention 
to improve mediolateral 
stability in walking where foot 
orthoses have not resolved 
associated symptoms.
Adjunct
Used simultaneously with foot orthoses in:
1. Children with significant foot and ankle instability associated with 
tripping and falling.
2. Children with insufficiency of posterior tibialis function.
3. Children with conditions associated with motor delay.
*Other assistive devices to include AFOs, crutches, foot orthoses, standing frames and walking frames.
†Adjunct AFO with stability footwear intervention requires a review of prescription of the sole to address any potential exacerbation of knee 
hyperextension in midstance.
AFO, ankle foot orthoses; GMFCS, Gross Motor Functioning Classification Score; HKAFO, hip knee ankle foot orthoses; KAFO, knee ankle 
foot orthoses.
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It was also noted by panellists that the foot anatomy of 
children with Down’s syndrome presents a challenge 
with footwear fitting. Therefore, the practitioner should 
consider available last adaptions to accommodate the 
dimensions of these children during prescription (85% 
agreement).
Two of the seven originally proposed conditions 
suggested from the scoping review toe walking and intoeing 
failed to reach any consensus statements concerning the 
suitability and clinical indications for stability footwear 
intervention. However, it must be noted that idiopathic 
toe walking moved closer towards consensus statements 
for clinical indications (range 60%–67% agreement) 
than intoeing (range 25%–44% agreement).
Outcome measures proposed by the panellist were 
broadly aligned to biomechanical, physiological, gross 
motor proficiency and quality of life (QoL) measures. 
In relation to biomechanical measures, ankle range of 
motion reached consensus as an outcome measure for 
cerebral palsy, symptomatic pes planus and Duchenne 
muscular dystrophy (range 80%–88% agreement). Spatio-
temporal outcome measures including walking velocity, 
6 min walk test and Timed Up and Go reached consensus 
among the five conditions (range 77%–90% agreement). 
Kinematic outcome measures also achieved consensus 
among the five groupings (range 77%–90% agreement); 
these were in relation to optimising gait movement 
patterns of the foot and ankle against disease- specific 
scores, Edinburgh Gait Score and Hoffer Ambulation 
Score or normal available data sets. None of the suggested 
kinetic outcome measures achieved a consensus level of 
agreement (range 60%–67% agreement). Physiological 
outcome measures concerning cardiovascular and meta-
bolic exertion were proposed and reached consensus 
(range 75%–91% agreement) for cerebral palsy, spina 
bifida and mobile pes planus. Outcome measures based 
on the child’s ability to perform activities via measures 
of gross motor skills reached a consensus among the 
five conditions (range 75%–88% agreement) (table 4). 
Consensus was also reached by the panel in that suitability 
of physical outcome measures must consider the stage/
grade of Duchenne muscular dystrophy and the capa-
bility of the child to perform the tasks (88% agreement). 
QoL measures, pain and activities of daily living outcome 
measures for off- the- shelf stability footwear intervention 
reached consensus agreement for all five conditions to 
a relatively high level (range 79%–100% agreement). 
With the majority of QoL outcome measures reaching 
consensus on initial consideration in round 2.
DISCUSSION
Despite the historical and relatively common usage of 
clinical footwear interventions in children with mobility 
impairment,5 6 there has been a lack of common under-
standing of how to define and characterise this interven-
tion. The collective opinion of the expert panel and the 
consensus formed through the inductive and iterative 
process of this study allowed novel ideas to be synthesised 
alongside previously published information. Clinical foot-
wear interventions for children with mobility impairment 
reached a common understanding and were collectively 
Table 4 Clinical outcome measures for off- the- shelf stability therapeutic footwear in children with mobility impairment
Biomechanical Physiological Gross motor proficiency Quality of life measures
Kinematic




Static Ankle Range of Motion:
Passive§: measured with the knee 
flexed and extended within the 
child’s limits
Weightbearing lunge¶: provided 
child can safely stand and get the 












Four square step test
Paediatric pain scale
Daily mobility and social 
interaction
*Outcomes must consider the stage/grade of the condition and the capability of the child to perform the tasks.
†Specific outcome for cerebral palsy.
‡Specific outcome for spina bifida.
§Range of motion outcome for cerebral palsy and symptomatic mobile pes planus
¶Range of motion outcome for cerebral palsy, Symptomatic mobile pes planus and duchenne muscular dystrophy
**Physiological outcomes for cerebral palsy, symptomatic mobile pes planus and spina bifida.
††Gross motor proficiency outcome for cerebral palsy, symptomatic mobile pes planus and Down’s syndrome.
6MWT, 6 min walk test; TUG, Timed Up and Go.
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grouped and defined under the overarching term thera-
peutic footwear. This allowed the identification and cate-
gorisation of one of the more potentially effective of these 
interventions, stability footwear9 as a subgrouping of func-
tional footwear. The process also provided a consensus 
understanding of the ideal design characteristics for off- 
the- shelf stability therapeutic footwear and how this inter-
vention may be used in a range of childhood mobility 
impairments. As stated, only one previous study had 
explored expert opinion on footwear as a clinical interven-
tion for children.4 The current study has provided a more 
detailed synthesis of expert opinion providing consensus 
on terms and definitions for children’s clinical footwear 
interventions in addition to identifying the specifics and 
purpose of off- the- shelf stability therapeutic footwear 
design and criteria for clinical prescription for children.
Section 1 sought to obtain consensus on definitions 
terms and groupings for clinical footwear interventions in 
children. Although this represented the smallest section 
in the total number of statements and open- ended 
questions in round 1, it received the most detailed and 
rich comments for qualitative analysis, underlining the 
potential contentiousness of this section. However, this 
was the only section that received a consensus statement 
for each area presented to the panel. It is highlighted 
that a consistent language of terms and definitions is 
required in healthcare practice to improve interprofes-
sional communication, healthcare research and provide 
optimal patient outcomes.8 27 The suggested terms defi-
nitions and groupings, incorporating children’s footwear 
interventions from this study, have been obtained using a 
valid consensus approach.15
The survey also sought to focus on off- the- shelf stability 
therapeutic footwear, which is a potentially effective foot-
wear intervention for children’s mobility impairment9 
The survey provided consensus agreement of a number 
of ideal design characteristics that should be offered on 
off- the- shelf stability therapeutic footwear for children, 
and the purpose of these. Identification of the key design 
specifics of an assistive aid affords an understanding of 
how and where the aid should support and assist mobility 
and has been used to help develop interventions such as 
AFOs.27–29 However, the panellists pointed out there was 
a limited evidence base to support these stability design 
characteristics. Some panellist proposed potential neuro-
dynamic properties of the footwear through proprio-
ceptive feedback at the heel counter and extended 
topline. However, panellists felt that further evidence was 
required to justify this claim. In comparison with stability 
features of the footwear, the panellists appeared more 
certain with their opinion on ergonomic factors as this 
achieved consensus in earlier rounds and is probably due 
to the established body of work in footwear science that 
relates comfort and fit to function.30–33 Although there is 
a lack of evidence to substantiate the design characteris-
tics purported to offer stability, the identification of these 
areas may inform further mechanical testing of off- the- 
shelf stability therapeutic footwear.
In addition to the design characteristics of children’s off- 
the- shelf stability therapeutic footwear, the survey sought 
to gain opinion and consensus on the clinical criteria for 
providing this footwear and the outcome measures to 
ascertain its effectiveness. Uncertainty on prescription 
criteria and goals of treatment can lead to inconsistent 
practice and lack of confidence in providing assistive aids 
to mobility- impaired children.34 35 This section initially 
started with the least number of statements in round 1 but 
went on to generate a total of 149 statements for panel-
list consideration. Criteria for prescription were largely to 
improve mediolateral stability in mobility and standing. 
Off- the- shelf stability therapeutic footwear may often be 
prescribed by clinicians as a first- line intervention based 
on historical practice. However, expert consensus recom-
mends that prescription of this footwear be assessed 
critically against the mobility needs of the child and the 
evidence base of other assistive devices, with the most 
suitable intervention being issued. Off- the- shelf stability 
footwear was to be used simultaneously with other assis-
tive devices (AFOs KAFOs walking frames) in more severe 
gradings (Gross Motor Functioning Classification Score 
(GMFCS) 2–4) with only minor gradings indicated for 
sole line treatment with off- the- shelf stability therapeutic 
footwear (GMFCS 1). The exception to this was symptom-
atic pes planus where it may be used only as a secondary 
line intervention after foot orthoses had failed to 
resolve symptoms. Body structure and function outcome 
measures were chiefly focused on spatiotemporal and 
kinematic measures in addition to the physiological cost. 
Kinetic measures did not reach consensus; however, this 
was largely due to the perceived compliance with in- shoe 
measurement devices and availability of force plates in 
clinical settings rather than the validity of these outcome 
measures. It was, therefore, uncertain if the panellists 
considered if outcomes were inclusive of research settings 
as well as daily clinical practice. QoL measures appeared 
to be considered an important outcome for off- the- shelf 
stability therapeutic footwear intervention in children with 
mobility impairment as these reached a higher frequency 
of strongly agree and in earlier rounds compared with the 
other outcomes. Conversely, the current body of research 
is limited, exploring the effects of footwear interventions 
on the QoL of children.9
Idiopathic toe walking and intoeing did not achieve 
any consensus for clinical criteria of off- the- shelf stability 
therapeutic footwear provision. Idiopathic toe walking 
was not felt by the panel to be completely unsuitable for 
off- the- shelf stability therapeutic footwear intervention. It 
was noted that it presented with a nebulous aetiology with 
variable responses to many interventions.36 The establish-
ment of criteria therefore required more complex strati-
fication than the closed- ended statements offered in the 
current survey. Intoeing again was cited as heterogeneous 
in nature37; however, this achieved the highest frequency 
of panellists scoring disagree or strongly disagree with 
panellists reaching a general consensus there was no clear 
evidence base to indicate off- the- shelf stability therapeutic 
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footwear for this clinical presentation even in the subcat-
egories suggested by the modified statements offered 
across rounds 2 and 3.
Five further conditions were suggested through 
consensus of the panellists; however, it was beyond the 
capacity of the current survey to explore the clinical 
criteria and proposed outcomes for off- the- shelf stability 
therapeutic footwear intervention in these additional 
conditions. This will require further exploratory work 
among experts in the area of clinical footwear provision 
to establish this.
The Medical Research Council38 provides a list of 
recommendations in developing and evaluating complex 
interventions. Paramount to the development process is 
that an intervention should be able to be fully defined 
in what it is expected to do and under what situations. 
There should be a full understanding of the components 
of the intervention and how these should act, who the 
intervention is aimed at and what the salient outcome 
measures expected to be achieved.7 38 The results of the 
Delphi consensus process have outlined and defined the 
spectrum of roles footwear may play as a clinical inter-
vention. Further to this, the results of the study provided 
an expert consensus of off- the- shelf stability therapeutic 
footwear including the identification of the design char-
acteristics purported to enhance mediolateral stability in 
children’s gait, the childhood mobility impairments that 
may benefit from stability footwear intervention and the 
necessary outcomes to evaluate the footwear’s effective-
ness in these children. While this consensus has iden-
tified several design characteristics, which the experts 
considered pertinent for off- the- shelf stability therapeutic 
footwear, further consideration should be given on how 
to assess these characteristics using mechanical testing 
procedures and in turn link them to International Orga-
nization for Standardization (ISO standards.
The Delphi technique has limitations in that it does 
not necessarily produce the right or definitive answers; 
instead, it produces a valid consensus of expert opinion.21 
The method uses both qualitative and quantitative anal-
ysis in a mixed- method approach; however, the data 
provided from Delphi’s are of inductive level 5 evidence39 
and are not authoritative requiring further deductive 
empirical research to support the findings of the work.15 
The recruitment to the Delphi panel was limited to 
countries with English as their first language, and poten-
tial differences in expert opinions may exist outside the 
selected experts’ countries (Australia, UK and USA). We 
actively sought a range of professionals from both the clin-
ical and manufacturing sectors to have a full, balanced 
understanding of the design specifics and purpose of 
the footwear. While there is a possibility of unconscious 
bias among the participants’ response as a result of their 
personal affiliations with either the clinical and commer-
cial sectors, it has certainly not affected the credibility of 
the results. Although we did not require a formal declara-
tion of conflict of interest, the professionals were required 
to state their role in children’s footwear intervention and 
any conflict of interests has been detailed on the table of 
participant characteristics.
The themes were derived by content analysis performed 
by one author. This may potentially have introduced some 
bias in interpretation of the expert opinions; however, 
this was mitigated by a collective agreement of statement 
generation between the authors from the themes, and 
the opportunity for panellists to correct any misrepresen-
tation or omission of their opinions in the subsequent 
Delphi rounds.
This study has achieved an expert consensus on 
defining and grouping clinical footwear interventions for 
children, where none previously existed. Additionally, the 
ideal design characteristics for off- the- shelf stability ther-
apeutic footwear for children with mobility impairment 
and suitable clinical populations for their provision have 
been identified.
The consensus will facilitate:
 ► A common understanding of therapeutic footwear 
terminology to facilitate communication between 
clinicians, researchers and manufacturers.
 ► Research- informed evidence for selection of appro-
priate off- the- shelf stability therapeutic footwear 
based on identified design characteristics.
 ► Research- informed evidence for dispensing off- the- 
shelf stability therapeutic footwear to suitable clinical 
populations.
 ► Standardised outcome measures for clinical assess-
ment of the effectiveness of off- the- shelf stability ther-
apeutic footwear interventions.
CONCLUSION
The current study is the first to establish a structured 
synthesis of expert opinion on defining and grouping 
children’s therapeutic footwear, in addition to identifying 
the design characteristics of off- the- shelf stability thera-
peutic footwear and relevant criteria for clinical prescrip-
tion. Also, this study, through clear terminology and 
definitions, provides a framework for the development of 
appropriate mechanical testing methods for off- the- shelf 
stability therapeutic footwear.
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